Issued Patents All Time
Showing 51–75 of 294 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10213401 | Immunomodulatory and differentiating function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy | Martin E. Sanders | 2019-02-26 |
| 10201512 | Autoimmune disorder treatment using RXR agonists | Ethan Dmitrovsky, Elizabeth Nowak, Randolph J. Noelle | 2019-02-12 |
| 10188618 | Treatment of cancer with specific RXR agonists | — | 2019-01-29 |
| 10123982 | Receptor subtype and function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy | Martin E. Sanders | 2018-11-13 |
| 10092535 | Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones | Martin E. Sanders | 2018-10-09 |
| 10039731 | Treatment of cancer with specific RXR agonists | — | 2018-08-07 |
| 10034845 | Autoimmune disorder treatment using RXR agonists | Ethan Dmitrovsky, Elizabeth Nowak, Randolph J. Noelle | 2018-07-31 |
| 10004709 | Receptor subtype and function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy | Martin E. Sanders | 2018-06-26 |
| 10004708 | Receptor subtype and function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy | Martin E. Sanders | 2018-06-26 |
| 9907768 | Receptor subtype and function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy | Martin E. Sanders | 2018-03-06 |
| 9877941 | Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones | Martin E. Sanders | 2018-01-30 |
| 9717702 | Treatment of cancer with specific RXR agonists | — | 2017-08-01 |
| 9655872 | Treatment of cancer with specific RXR agonists | — | 2017-05-23 |
| 9308186 | Treatment of cancer with specific RXR agonists | — | 2016-04-12 |
| 9271946 | Use of a RAR antagonist or inverse agonist for the treatment of chemotherapy and/or radiation therapy side effects | Yang-Dar Yuan | 2016-03-01 |
| 8101662 | Treatment of cancer with specific RXR agonists | — | 2012-01-24 |
| 7638648 | Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same | Jayasree Vasudevan, Liming Wang, Xiaoxia Liu, Kwok Yin Tsang, Ling Li +5 more | 2009-12-29 |
| 7476673 | Disubstituted chalcone oximes as selective agonists of RARγ retinoid receptors | Kwok Yin Tsang, Santosh C. Sinha, Xiaoxia Liu, Smita S. Bhat | 2009-01-13 |
| 7468391 | Methods for treating retinoid responsive disorders using selective inhibitors of CYP26A and CYP26B | Jayasree Vasudevan, Rong Yang, Liming Wang, Xiaoxia Liu, Kwok Yin Tsang +5 more | 2008-12-23 |
| 7432388 | Disubstituted chalcone oximes having RARγ retinoid receptor antagonist activity | Kwok Yin Tsang, Santosh C. Sinha, Xiaoxia Liu, Smita S. Bhat | 2008-10-07 |
| 7351737 | 4-[(8-substituted)-6-chromanoyl]-and 4-[8-substituted)-chroman-6-YL-ethynyl]-benzoic and phenylacetic acids, their esters and salts having cytochrome P450RAI inhibitory activity | Jayasree Vasudevan, Liming Wang, Xiaoxia Liu, Kwok Yin Tsang, Yang-Dar Yuan | 2008-04-01 |
| 7253319 | Disubstituted chalcone oximes having RARγ retinoid receptor antagonist activity | Kwok Yin Tsang, Santosh C. Sinha, Xiaoxia Liu, Smita S. Bhat | 2007-08-07 |
| 7226951 | Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same | Jayasree Vasudevan, Liming Wang, Xiaoxia Liu, Kwok Yin Tsang, Ling Li +5 more | 2007-06-05 |
| 7166726 | Aryl substituted 3,4-dihydroanthracene derivatives having retinoid antagonist or retinoid inverse agonist type biological activity | Vidyasagar Vuligonda, Alan T. Johnson | 2007-01-23 |
| 7105566 | Methods of treatment during vascular procedures | Yang-Dar Yuan, Tuong P. Dang, Sheng Z. Loh | 2006-09-12 |